87 related articles for article (PubMed ID: 20133893)
1. Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.
Chillón MC; Santamaría C; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Marín L; Caballero MD; Vidriales MB; Ramos F; Bernal T; Díaz-Mediavilla J; García de Coca A; Peñarrubia MJ; Queizán JA; Giraldo P; San Miguel JF; González M
Haematologica; 2010 May; 95(5):745-51. PubMed ID: 20133893
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and genetic characteristics of patients with newly diagnosed acute promyelocytic leukemia: a single-center retrospective of 790 cases].
Yang MZ; Li L; Wei H; Liu BC; Liu KQ; Li DP; Zhang L; Yang RC; Mi YC; Wang JX; Wang Y
Zhonghua Xue Ye Xue Za Zhi; 2022 Apr; 43(4):336-341. PubMed ID: 35680634
[No Abstract] [Full Text] [Related]
3. Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.
Barragán E; Montesinos P; Camos M; González M; Calasanz MJ; Román-Gómez J; Gómez-Casares MT; Ayala R; López J; Fuster Ó; Colomer D; Chillón C; Larrayoz MJ; Sánchez-Godoy P; González-Campos J; Manso F; Amador ML; Vellenga E; Lowenberg B; Sanz MA; ;
Haematologica; 2011 Oct; 96(10):1470-7. PubMed ID: 21685470
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA.
Schnittger S; Bacher U; Haferlach C; Kern W; Alpermann T; Haferlach T
Haematologica; 2011 Dec; 96(12):1799-807. PubMed ID: 21859732
[TBL] [Abstract][Full Text] [Related]
6. Acute Promyelocytic Leukemia with Rare Genetic Aberrations: A Report of Three Cases.
Liu G; Liu L; Bartolo DD; Li KY; Li X
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672788
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Successful therapy with all-
Chen L; Zhu H; Zhu Y; Jin W; Dong F; Li J; Hu J; Chen Q; Wang K; Li J
Front Oncol; 2022; 12():1013046. PubMed ID: 36212492
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
Testa U; Lo-Coco F
Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
[TBL] [Abstract][Full Text] [Related]
9. A Bayesian hierarchical monitoring design for phase II cancer clinical trials: Incorporating information on response duration into monitoring rules.
Wang J; Ma J; Cai C; Daver N; Ning J
Stat Med; 2021 Sep; 40(21):4629-4639. PubMed ID: 34101217
[TBL] [Abstract][Full Text] [Related]
10.
Li AY; Kashanian SM; Hambley BC; Zacholski K; Duong VH; El Chaer F; Holtzman NG; Gojo I; Webster JA; Norsworthy KJ; Smith BD; DeZern AE; Levis MJ; Baer MR; Kamangar F; Ghiaur G; Emadi A
Biology (Basel); 2021 Mar; 10(3):. PubMed ID: 33800974
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related acute promyelocytic leukemia with FMS-like tyrosine kinase 3-internal tandem duplication mutation in solitary bone plasmacytoma: A case report.
Hong LL; Sheng XF; Zhuang HF
World J Clin Cases; 2020 Oct; 8(19):4579-4587. PubMed ID: 33083421
[TBL] [Abstract][Full Text] [Related]
12. Higher Level of Peripheral Blood CD34 Positive Cells Presented with Unfavorable Prognosis in Intermediate-Low Risk Acute Promyelocytic Leukemia.
Zhang C; Dong H; Lin Y; Xu P; Zhou R; Zeng H
Indian J Hematol Blood Transfus; 2020 Apr; 36(2):309-315. PubMed ID: 32425382
[TBL] [Abstract][Full Text] [Related]
13. The Impact of
Picharski GL; Andrade DP; Fabro ALMR; Lenzi L; Tonin FS; Ribeiro RC; Figueiredo BC
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31492033
[TBL] [Abstract][Full Text] [Related]
14. The novel three-way variant t(6;17;15)(p21;q21;q22) in acute promyelocytic leukemia with an FLT3-ITD mutation: A case report.
Zhang YL; Jiang M; Luan SQ; Liu SY; Wan JH; Wan LG; Zhang ZL
Oncol Lett; 2018 Nov; 16(5):6121-6125. PubMed ID: 30344754
[TBL] [Abstract][Full Text] [Related]
15. Early mortality in acute promyelocytic leukemia: Potential predictors.
Chen C; Huang X; Wang K; Chen K; Gao D; Qian S
Oncol Lett; 2018 Apr; 15(4):4061-4069. PubMed ID: 29541170
[TBL] [Abstract][Full Text] [Related]
16. FLT3-ITD and its current role in acute myeloid leukaemia.
Lagunas-Rangel FA; Chávez-Valencia V
Med Oncol; 2017 Jun; 34(6):114. PubMed ID: 28470536
[TBL] [Abstract][Full Text] [Related]
17. Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia.
Bochtler T; Fröhling S; Weichert W; Endris V; Thiede C; Hutter B; Hundemer M; Ho AD; Krämer A
Cold Spring Harb Mol Case Stud; 2016 Sep; 2(5):a001123. PubMed ID: 27626069
[TBL] [Abstract][Full Text] [Related]
18. PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.
Cicconi L; Divona M; Ciardi C; Ottone T; Ferrantini A; Lavorgna S; Alfonso V; Paoloni F; Piciocchi A; Avvisati G; Ferrara F; Di Bona E; Albano F; Breccia M; Cerqui E; Sborgia M; Kropp MG; Santoro A; Levis A; Sica S; Amadori S; Voso MT; Mandelli F; Lo-Coco F
Leukemia; 2016 Oct; 30(10):1987-1992. PubMed ID: 27133819
[TBL] [Abstract][Full Text] [Related]
19. Acute promyelocytic leukemia harbouring rare
Liu TT; Zeng KE; Wang L; Liu T; Niu T
Oncol Lett; 2015 Sep; 10(3):1858-1862. PubMed ID: 26622765
[TBL] [Abstract][Full Text] [Related]
20. Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivo.
Arreba-Tutusaus P; Mack TS; Bullinger L; Schnöder TM; Polanetzki A; Weinert S; Ballaschk A; Wang Z; Deshpande AJ; Armstrong SA; Döhner K; Fischer T; Heidel FH
Leukemia; 2016 May; 30(5):1220-1225. PubMed ID: 26487272
[No Abstract] [Full Text] [Related]
[Next] [New Search]
